These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6486045)

  • 1. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin.
    McComb JM; Campbell NP; Cleland J
    Am J Cardiol; 1984 Oct; 54(7):922-3. PubMed ID: 6486045
    [No Abstract]   [Full Text] [Related]  

  • 2. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion.
    Guelon D; Bedock B; Chartier C; Haberer JP
    Am J Cardiol; 1986 Sep; 58(7):666. PubMed ID: 3751946
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).
    Schoenenberger RA; Haefeli WE; Weiss P; Ritz RF
    BMJ; 1990 May; 300(6736):1375-6. PubMed ID: 2372583
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block].
    Brixius B; Lindinger A; Baghai A; Limbach HG; Hoffmann W
    Klin Padiatr; 1999; 211(6):465-8. PubMed ID: 10592929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.
    Nattel S; Ranger S; Talajic M; Lemery R; Roy D
    Am J Med; 1990 Aug; 89(2):235-8. PubMed ID: 2382671
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement.
    Lam BK; Chan V; Hendry P; Ruel M; Masters R; Bedard P; Goldstein B; Rubens F; Mesana T
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1464-73. PubMed ID: 17532940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent ventricular tachycardia; a late complication of mitral valve replacement.
    Feldman IM; Criley JM; Nelson RJ; Cleveland RJ
    Chest; 1971 Oct; 60(4):401-4. PubMed ID: 5115866
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
    Ponsonnaille J; Citron B; Richard A; Trolese JF; Chaperon A; Barret B; Gras H
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1001-8. PubMed ID: 3144248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bidirectional ventricular tachycardia. Description of 2 cases].
    Costantini M; Salerno JA; Chimienti M; Panciroli C; Bobba P
    Cardiologia; 1983 Dec; 28(12):1053-63. PubMed ID: 6687207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Jet intravenous injection of erythromycin lactobionate. A possible cause of the occurrence of crisis in torsade de pointe].
    Camilleri JF; Deharo JC; Panagidès D; Broin P; Mésana T; Blin D; Mouly-Bandini A; Dubouloz C; Goudard A; Montiès JR
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(10):657-9. PubMed ID: 2698118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Brandriss MW; Richardson WS; Barold SS
    Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long QT syndrome and torsades de pointes complicating mitral valve replacement.
    Gilbert S; Singh D; Jesuraj ML
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S210-S211. PubMed ID: 27751291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REPLACEMENT OF THE AORTIC AND MITRAL VALVES USING THE STARR-EDWARDS BALL-VALVE PROSTHESIS: A REPORT OF 50 CASES.
    CALLAGHAN JC
    Can Med Assoc J; 1964 Aug; 91(9):411-21. PubMed ID: 14179062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of the intraatrial ECG to recognize digitalis induced atrial arrhythmias (author's transl)].
    Gattenlöhner W; Wiessmann B
    Med Klin; 1976 Jan; 71(5):202-4. PubMed ID: 1250200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tachycardia on the function of the Starr-Edwards mitral ball valve prosthesis.
    Conkle DM; Hannah HH; Reis RL
    Am J Cardiol; 1973 Jan; 31(1):105-7. PubMed ID: 4682403
    [No Abstract]   [Full Text] [Related]  

  • 19. Irregular tachycardia after cardiac surgery.
    Hancock EW
    Hosp Pract (Off Ed); 1990 Jan; 25(1):83-4. PubMed ID: 2104872
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical management of refractory ventricular arrhythmias in patients with prior inferior myocardial infarction. A preliminary report.
    Ivey TD; Brady GH; Misbach GA; Greene HL
    J Thorac Cardiovasc Surg; 1985 Mar; 89(3):369-77. PubMed ID: 3974272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.